期刊文献+

青海地区不同民族结直肠癌错配修复蛋白表达及其临床意义 被引量:2

Expression of Mismatched Repair Proteins in Colorectal Cancer of Different Ethnic Groups in Qinghai Province and its Clinical Significance
下载PDF
导出
摘要 目的分析青海地区汉、藏、回族结直肠癌4种错配修复蛋白(MMR)(MLH1、MSH6、MSH2、PMS2)的表达情况,探讨与结直肠癌临床病理特征和生存预后之间的关系。方法收集我院2016年1月至2019年6月手术切除的312例结直肠癌标本(其中汉族164例、藏族83例、回族65例),取手术切除的结直肠癌组织标本,采用免疫组化法检测MMR表达情况。用PBS代替一抗作为阴性对照,用正常的结直肠癌黏膜上皮作为阳性对照。结果312例结直肠癌标本中错配修复蛋白表达缺失(dMMR)56例,表达缺失率17.9%;其中仅MLH1蛋白表达缺失12例(3.8%),仅MSH2蛋白表达缺失25例(8.0%),仅MSH6蛋白表达缺失8例(2.6%),仅PMS2蛋白表达缺失11例(3.5%),MLH1和PMS2蛋白表达均缺失19例(6.1%),MSH2和MSH6蛋白表达均缺失18例(5.8%)。MMR蛋白表达情况与结直肠癌临床病理特征之间的关系分析发现,MMR蛋白表达缺失与年龄、性别、浸润深度、民族无关,与pTNM分期、发病部位、淋巴结转移情况、病理组织学有关(P<0.05);错配修复蛋白表达完整(pMMR)、dMMR患者的中位无病生存期(DFS)分别是13.3个月和22.7个月,经Log-rank检验dMMR患者的DFS明显长于pMMR的患者(χ^(2)=98.587,P<0.001)。结论青海地区结直肠癌患者dMMR在不同民族之间表达无显著差异,肿瘤发病部位、pTNM分期、病理组织学、淋巴结转移情况影响结直肠癌中MMR的表达,dMMR的结直肠癌患者DFS更长。 Objective To analyze the expression of four kinds of mismatch repair protein(MMR)(MLH1,PMS2,MSH6,MSH2)in colorectal cancer of Han,Tibetan and Hui nationality in Qinghai province,and explore the relationship between clinicopathological features and survival prognosis.Methods From January 2016 to June 2019,312 cases of colorectal cancer were collected in Qinghai people's Hospital,including 164 cases of Han,83 cases of Tibetans and 65 cases of Hui.Colorectal cancer tissue specimens were taken from surgical resection.MMR expressions were detected by immunohistochemical method.PBS was used as negative control,and normal colorectal mucosal epithelium was used as positive control.Results The ficiency expression of MMR(dMMR)was found in 56/312 cases(17.9%).Among them,only MLH1 protein expression was absent in 12/312 cases(3.8%),only MSH2 protein expression was absent in 25/312 cases(8.0%),only MSH6 protein expression was absent in 8/312 cases(2.6%),only PMS2 protein expression was absent in 11/312 cases(3.5%),MLH1 and PMS2 protein expression were absent in 19/312 cases(6.1%),and MSH2 and MSH6 protein expression were absent in 18/312 cases(5.8%).Relationship analysis between MMR and clinicopathological features of colorectal cancer showed that the loss of MMR protein expression was not related to age,gender,nationality and depth of invasion,while it was related to pTNM stage,location,lymph node metastasis and histopathology(P<0.05).The median disease-free survival time(DFS)of mismatch repair protein expression deletion(dMMR)and mismatch repair protein expression intact(pMMR)was 22.7 months and 13.3 months,respectively.Log-rank test showed that DFS of dMMR patients was significantly longer than that of pMMR patients(χ^(2)=98.587,P<0.001).Conclusion There is no significant difference in dMMR expression of colorectal cancer patients in Qinghai among different ethnic groups.Tumor site,pTNM stage,histopathology and lymph node metastasis could affect MMR expression in colorectal cancer patients,and DFS in colorectal cancer pat
作者 袁青玲 王冬梅 杨娟 赞梅 宋晓燕 肖成华 张梦岚 本巴吉 Yuan Qingling;Wang Dongmei;Yang Juan(Qinghai Provincial People′s Hospital,Xining,Qinghai 810007,China)
机构地区 青海省人民医院
出处 《四川医学》 CAS 2021年第7期693-697,共5页 Sichuan Medical Journal
关键词 结直肠癌 错配修复蛋白 临床病理特征 免疫组织化 mismatch repair protein colorectal cancer immunohistochemistry clinicopathological features
  • 相关文献

参考文献9

二级参考文献71

  • 1马俊丽,曾珊.错配修复基因和结肠癌的关系[J].中南大学学报(医学版),2014,39(2):190-194. 被引量:13
  • 2许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1365
  • 3Rebecca Siegel,Deepa Naishadham,Ahmedin Jemal.Cancer statistics, 2013[J]. CA: A Cancer Journal for Clinicians . 2013 (1) 被引量:122
  • 4Ryota Nakanishi,Jun Harada,Munkhbold Tuul,Yan Zhao,Koji Ando,Hiroshi Saeki,Eiji Oki,Takefumi Ohga,Hiroyuki Kitao,Yoshihiro Kakeji,Yoshihiko Maehara.Prognostic relevance of KRAS and BRAF mutations in Japanese patients with colorectal cancer[J].International Journal of Clinical Oncology.2013(6) 被引量:2
  • 5Hyoung Ran Kim,Hee Cheol Kim,Hae-Ran Yun,Seok Hyung Kim,Cheol Keun Park,Yong Beom Cho,Seong Hyeon Yun,Woo Yong Lee,Ho-Kyung Chun.An Alternative Pathway in Colorectal Carcinogenesis Based on the Mismatch Repair System and p53 Expression in Korean Patients with Sporadic Colorectal Cancer[J].Annals of Surgical Oncology.2013(12) 被引量:1
  • 6Paul Lochhead,Aya Kuchiba,Yu Imamura,Xiaoyun Liao,Mai Yamauchi,Reiko Nishihara,Zhi Rong Qian,Teppei Morikawa,Jeanne Shen,Jeffrey A. Meyerhardt,Charles S. Fuchs,Shuji Ogino.Microsatellite Instability and BRAF Mutation Testing in Colorectal Cancer Prognostication[J].JNCI Journal of the National Cancer Institute.2013(15) 被引量:3
  • 7Marjolijn J. L. Ligtenberg,Roland P. Kuiper,Ad Geurts van Kessel,Nicoline Hoogerbrugge.EPCAM deletion carriers constitute a unique subgroup of Lynch syndrome patients[J].Familial Cancer.2013(2) 被引量:1
  • 8Sae‐Won Han,Hyun‐Jung Lee,Jeong Mo Bae,Nam‐Yun Cho,Kyung‐Hun Lee,Tae‐Yong Kim,Do‐Youn Oh,Seock‐Ah Im,Yung‐Jue Bang,Seung‐Yong Jeong,Kyu Joo Park,Jae‐Gahb Park,Gyeong Hoon Kang,Tae‐You Kim.Methylation and microsatellite status and recurrence following adjuvant FOLFOX in colorectal cancer[J].Int J Cancer.2012(9) 被引量:2
  • 9Li-Ling Hsieh,Tze-Kiong Er,Chih-Chieh Chen,Jan-Sing Hsieh,Jan-Gowth Chang,Ta-Chih Liu.Characteristics and prevalence of KRAS , BRAF , and PIK3CA mutations in colorectal cancer by high-resolution melting analysis in Taiwan Residents population[J].Clinica Chimica Acta (-).2012(19-20) 被引量:1
  • 10Ye-Young Rhee,Mi Kim,Jeong Bae,Jae Koh,Nam-Yun Cho,Yong-Sung Juhnn,Donguk Kim,Gyeong Kang.Clinical Outcomes of Patients with Microsatellite-Unstable Colorectal Carcinomas Depend on L1 Methylation Level[J].Annals of Surgical Oncology.2012(11) 被引量:2

共引文献83

同被引文献22

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部